Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESH AL 2020 | ESH AL highlights: management of T-cell malignancies

John DiPersio, MD, PhD, Washington University School of Medicine, Washington, WA, discusses emerging treatment approaches for T-cell malignancies and shares his key take-home messages from this year’s ESH AL meeting. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).